Marco Dioguardi Burgio1,2, Thomas Benseghir3, Vincent Roche1, Carmela Garcia Alba1, Jean Baptiste Debry1, Annie Sibert1, Valérie Vilgrain1,2,4, Maxime Ronot5,6,7. 1. Department of Radiology, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-Seine, France. 2. INSERM U1149, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3, Paris, France. 3. GE Healthcare, Buc, France. 4. University Paris Diderot, Sorbonne Paris Cité, Paris, France. 5. Department of Radiology, University Hospitals Paris Nord Val de Seine, Beaujon, Clichy, Hauts-de-Seine, France. maxime.ronot@aphp.fr. 6. INSERM U1149, Centre de Recherche Biomédicale Bichat-Beaujon, CRB3, Paris, France. maxime.ronot@aphp.fr. 7. University Paris Diderot, Sorbonne Paris Cité, Paris, France. maxime.ronot@aphp.fr.
Abstract
OBJECTIVES: To assess the impact of recently developed respiratory motion correction software on contrast-enhanced cone beam CT angiography (CBCT-a) for intraprocedural image guidance during intra-arterial liver-directed therapy. METHODS: From 2015 to 2017, two groups of patients who underwent intra-arterial liver-directed therapy with (breathing, n = 30) or without (still, n = 30) significant respiratory motion artifacts were retrospectively included. All CBCT-a were processed with and without dedicated respiratory motion correction software. Four readers independently assessed the following in both reconstructions (motion correction ON and OFF): (1) overall image quality on a 0-to-5 point scale, and (2) presence of relevant peri-procedural information on tumor and vasculature (overall vessel geometry, visibility of extrahepatic vessels, target tumor conspicuity, visibility of tumor feeders). RESULTS: Motion correction increased the average image quality in the breathing group from 2.0 ± 0.9 to 2.9 ± 1.0 (p < 0.01). The visibility of vessel geometry, extrahepatic vessels, and tumor feeders was significantly improved for all readers, and tumor conspicuity was improved for three readers. The average image quality was not significantly different between reconstructions in the still group (motion correction ON and OFF), for any of the readers (4.0 ± 0.6 vs 4.2 ± 0.6; p = 0.12). There was no change in the visibility of vessel geometry, extrahepatic vessels, tumor feeders, or tumor conspicuity for the four readers using the respiratory motion correction software in this group. CONCLUSIONS: Using the dedicated respiratory motion correction software during intra-arterial liver-directed procedures increases the visualization of relevant peri-procedural information and image quality in CBCT-a corrupted by respiratory motion artifacts without affecting these elements in still CBCT-a. KEY POINTS: • The use of respiratory motion correction software could reduce the need for cone beam CT angiography acquisition retake. • Motion correction software significantly increases the visibility of vessel geometry, extrahepatic vessels, and tumor feeders, as well as tumor conspicuity in cone beam CT angiography corrupted by respiratory motion artifacts. • The use of respiratory motion correction software on cone beam CT angiography uncorrupted by respiratory motion artifact does not result in decreased image quality.
OBJECTIVES: To assess the impact of recently developed respiratory motion correction software on contrast-enhanced cone beam CT angiography (CBCT-a) for intraprocedural image guidance during intra-arterial liver-directed therapy. METHODS: From 2015 to 2017, two groups of patients who underwent intra-arterial liver-directed therapy with (breathing, n = 30) or without (still, n = 30) significant respiratory motion artifacts were retrospectively included. All CBCT-a were processed with and without dedicated respiratory motion correction software. Four readers independently assessed the following in both reconstructions (motion correction ON and OFF): (1) overall image quality on a 0-to-5 point scale, and (2) presence of relevant peri-procedural information on tumor and vasculature (overall vessel geometry, visibility of extrahepatic vessels, target tumor conspicuity, visibility of tumor feeders). RESULTS: Motion correction increased the average image quality in the breathing group from 2.0 ± 0.9 to 2.9 ± 1.0 (p < 0.01). The visibility of vessel geometry, extrahepatic vessels, and tumor feeders was significantly improved for all readers, and tumor conspicuity was improved for three readers. The average image quality was not significantly different between reconstructions in the still group (motion correction ON and OFF), for any of the readers (4.0 ± 0.6 vs 4.2 ± 0.6; p = 0.12). There was no change in the visibility of vessel geometry, extrahepatic vessels, tumor feeders, or tumor conspicuity for the four readers using the respiratory motion correction software in this group. CONCLUSIONS: Using the dedicated respiratory motion correction software during intra-arterial liver-directed procedures increases the visualization of relevant peri-procedural information and image quality in CBCT-a corrupted by respiratory motion artifacts without affecting these elements in still CBCT-a. KEY POINTS: • The use of respiratory motion correction software could reduce the need for cone beam CT angiography acquisition retake. • Motion correction software significantly increases the visibility of vessel geometry, extrahepatic vessels, and tumor feeders, as well as tumor conspicuity in cone beam CT angiography corrupted by respiratory motion artifacts. • The use of respiratory motion correction software on cone beam CT angiography uncorrupted by respiratory motion artifact does not result in decreased image quality.
Authors: Ron C Gaba; R Peter Lokken; Ryan M Hickey; Andrew J Lipnik; Robert J Lewandowski; Riad Salem; Daniel B Brown; T Gregory Walker; James E Silberzweig; Mark Otto Baerlocher; Ana Maria Echenique; Mehran Midia; Jason W Mitchell; Siddharth A Padia; Suvranu Ganguli; Thomas J Ward; Jeffrey L Weinstein; Boris Nikolic; Sean R Dariushnia Journal: J Vasc Interv Radiol Date: 2017-06-29 Impact factor: 3.464
Authors: In Joon Lee; Jin Wook Chung; Yong Hu Yin; Hyo-Cheol Kim; Young Il Kim; Hwan Jun Jae; Jae Hyung Park Journal: J Vasc Interv Radiol Date: 2014-06-10 Impact factor: 3.464
Authors: Nishita Kothary; Mohamed H K Abdelmaksoud; Alessia Tognolini; Rebecca Fahrig; Jarrett Rosenberg; David M Hovsepian; Arundhuti Ganguly; John D Louie; William T Kuo; Gloria L Hwang; Alison Holzer; Daniel Y Sze; Lawrence V Hofmann Journal: J Vasc Interv Radiol Date: 2011-08-27 Impact factor: 3.464
Authors: Alessia Tognolini; John D Louie; Gloria L Hwang; Lawrence V Hofmann; Daniel Y Sze; Nishita Kothary Journal: J Vasc Interv Radiol Date: 2010-02-04 Impact factor: 3.464
Authors: Lena S Becker; Marcel Gutberlet; Sabine K Maschke; Thomas Werncke; Cornelia L A Dewald; Christian von Falck; Arndt Vogel; Roman Kloeckner; Bernhard C Meyer; Frank Wacker; Jan B Hinrichs Journal: Cardiovasc Intervent Radiol Date: 2020-12-06 Impact factor: 2.740